BusinessAgile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®By Nasdaq OMXJun 27, 2017, 12:00 PM UTC
BusinessAGRX NOTICE: Rosen Law Firm Reminds Agile Therapeutics Investors of Important Class Action Deadline – AGRXBy Nasdaq OMXFeb 15, 2017, 7:30 PM UTC
BusinessEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. – AGRXBy Nasdaq OMXJan 26, 2017, 5:16 PM UTC
